|
"di cosimo s"的相關文件
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2020-03-23T07:19:19Z |
Pattern of rash, diarrhea, and hepatic toxicities secondary to lapatinib and their association with age and response to neoadjuvant therapy: Analysis from the NeoALTTO trial
|
Hsieh R.K.; Vuylsteke P.; CHIUN-SHENG HUANG; Aktas B.; Kim S.-B.; Jackisch C.; Smith I.; Azim H.A.;Agbor-Tarh D.;Bradbury I.;Dinh P.;Baselga J.;Di Cosimo S.;Greger Jr. J.G.;Smith I.;Jackisch C.;Kim S.-B.;Aktas B.;Chiun-Sheng Huang;Vuylsteke P.;Hsieh R.K.;Dreosti L.;Eidtmann H.;Piccart M.;De Azambuja E.; Azim H.A.; Agbor-Tarh D.; Bradbury I.; Dinh P.; Baselga J.; Di Cosimo S.; Greger Jr. J.G.; De Azambuja E.; Piccart M.; Eidtmann H.; Dreosti L. |
| 臺大學術典藏 |
2020-03-23T07:19:13Z |
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): Survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
|
Xu B.; Boyle F.; Smith I.; Jackisch C.; Lang I.; Untch M.; Swaby R.F.; Di Cosimo S.; Holmes E.; Piccart-Gebhart M.; Holmes A.P.; De Azambuja E.;Holmes A.P.;Piccart-Gebhart M.;Holmes E.;Di Cosimo S.;Swaby R.F.;Untch M.;Jackisch C.;Lang I.;Smith I.;Boyle F.;Xu B.;Barrios C.H.;Perez E.A.;Azim H.A.;Kim S.-B.;Kuemmel S.;Chiun-Sheng Huang;Vuylsteke P.;Hsieh R.-K.;Gorbunova V.;Eniu A.;Dreosti L.;Tavartkiladze N.;Gelber R.D.;Eidtmann H.;Baselga J.; De Azambuja E.; Barrios C.H.; Perez E.A.; Azim H.A.; Kim S.-B.; Kuemmel S.; CHIUN-SHENG HUANG; Vuylsteke P.; Hsieh R.-K.; Gorbunova V.; Eniu A.; Dreosti L.; Tavartkiladze N.; Gelber R.D.; Eidtmann H.; Baselga J. |
| 臺大學術典藏 |
2018-09-10T09:52:25Z |
Pattern of rash, diarrhea, and hepatic toxicities secondary to lapatinib and their association with age and response to neoadjuvant therapy: Analysis from the NeoALTTO trial
|
Agbor-Tarh, D.; Bradbury, I.; Dinh, P.; Baselga, J.; Di Cosimo, S.; Greger Jr.; J.G.; Smith, I.; Jackisch, C.; Kim, S.-B.; Aktas, B.; Huang, C.-S.; Vuylsteke, P.; Hsieh, R.K.; Dreosti, L.; Eidtmann, H.; Piccart, M.; De Azambuja, E.; CHIUN-SHENG HUANG |
| 國立成功大學 |
2017 |
RNA sequencing to predict response to neoadjuvant anti-HER2 therapy a secondary analysis of the NeoALTTO randomized clinical trial
|
Fumagalli, D.;Venet, D.;Ignatiadis, M.;Azim, H.A.;Jr;Maetens, Maetens M.;Roth�, F.;Salgado, R.;Bradbury, I.;Pusztai, L.;Harbeck, N.;Gomez, H.;Chang, T.-W.;Coccia-Portugal, M.A.;Di, Cosimo S.;De, Azambuja E.;De, La Pe�a L.;Nuciforo, P.;Brase, J.C.;Huober, J.;Baselga, J.;Piccart, M.;Loi, S.;Sotiriou, C. |
| 臺大學術典藏 |
2016 |
Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: Results From the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial
|
Piccart-Gebhart M.; Holmes E.; Baselga J.; De Azambuja E.; Dueck A.C.; Viale G.; Zujewski J.A.; Goldhirsch A.; Armour A.; Pritchard K.I.; McCullough A.E.; Dolci S.; McFadden E.; Holmes A.P.; Tonghua L.; Im Y.-H.; CHIUN-SHENG HUANG; D?eras V.; Hillman D.W.; Wolff A.C.; Jackisch C.; Lang I.; Untch M.; Smith I.; Boyle F.; Xu B.; Gomez H.; Suter T.; Gelber R.D.; Perez E.A.; Eidtmann H.; Dinh P.; Di Cosimo S.; Harbeck N.; Tjulandin S. |
| 國立成功大學 |
2015-09 |
Expression levels of ERBB2, ESR1, immune and proliferation signatures measured by RNASeq predict response to anti-HER2 treatment in the neoALTTO trial
|
Sotiriou, C.; Venet, D.; Fumagalli, D.; Maetens, M.; Rothe, F.; Ignatiadis, M.; Bradbury, I.; Harbeck, N.; Gomez, H.; Chang, T. W.; Coccia-Portugal, M. A.; Di Cosimo, S.; De Azambuja, E.; De la Pena, L.; Nuciforo, P.; Armour, A.; Eidtmann, H.; Baselga, J.; Piccart, M.; Loi, S. |
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
|
